THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
External links
This page lists THERAVANCE BIOPHARMA INC's shareholders in Q3 2023. To view THERAVANCE BIOPHARMA INC's shareholder history, click here.